Log In
Print
BCIQ
Print
Print this Print this
 

ClonoSIGHT

  Manage Alerts
Collapse Summary General Information
Company Sequenta Inc.
DescriptionTest based on LymphoSIGHT technology platform which combines multiplexed PCR assays for sequencing immunoglobulin and T cell receptors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect minimal residual disease (MRD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today